It is a healthcare private limited company based in Secunderabad, Telangana, India, established in 2010.
2010 | Secunderabad, Telangana, India | ActiveSeranti Pharmaceuticals Private Limited, a active private limited company, was established on 04 November 2010 in Secunderabad, Telangana, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U24233TG2010PTC071088. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.16 M.
It upholds a compliant status. Its leadership includes Ahuti Rautaray (Managing Director), Susanta Senapati (Director). Past directors included Minati Senapati. It holds ₹4.72 M open charges and ₹1.85 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 3-3-66/Fc Surya Selter-I, Infront Of Bolaram Stati Risala Bazar Burtonguda, Secunderabad, Telangana, 500010.
U24233TG2010PTC071088
071088
04 November 2010
₹2.50 M
₹2.16 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Seranti Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ahuti Rautaray | Managing Director | 04 Nov 2010 | Current |
| Susanta Senapati | Director | 14 Dec 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Seranti Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.32% increase. The company also saw a slight improvement in profitability, with a 3.23% increase in profit. The company's net worth moved up by a moderate rise of 4.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Seranti Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹4,720,000.00
₹1,850,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2022 | Others | ₹0.48 M | Open |
| 30 Apr 2022 | Others | ₹0.24 M | Open |
| 31 May 2016 | Others | ₹4.00 M | Open |
| 20 Aug 2014 | Syndicate Bank | ₹1.35 M | Satisfied |
| 05 Dec 2013 | Oriental Bank Of Commerce | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Seranti Pharmaceuticals has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Seranti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seranti Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Seranti Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Seranti Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
A charge with Others of Rs. 4.00 M registered on 31 May 2016 with Charge ID 100038369 was modified on 24 Jun 2023. was recorded as a recent event.
A charge with Others amounted to Rs. 0.48 M with Charge ID 100569553 was registered on 30 Apr 2022. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.24 M with Charge ID 100569552 was registered on 30 Apr 2022. was documented.
Progress on Susanta Senapati was appointed as a Director was appointed as a Director on 14 Dec 2020 & has been associated with this company since 4 years 11 months . was documented.
The CIN of Seranti Pharmaceuticals Private Limited is U24233TG2010PTC071088.
Seranti Pharmaceuticals Private Limited is headquartered at 3-3-66/Fc Surya Selter-I, Infront Of Bolaram Stati Risala Bazar Burtonguda, Secunderabad, Telangana, 500010.
Seranti Pharmaceuticals Private Limited was incorporated on 04 November 2010.
The current directors of Seranti Pharmaceuticals Private Limited are
The primary industry of Seranti Pharmaceuticals Private Limited is Hospital And Medical Care.
Seranti Pharmaceuticals Private Limited is unlisted.
The authorized capital of Seranti Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.16 M.
The compliance status of Seranti Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX